Injectable GIP/GLP-1 treatments are among the most effective prescription treatments available for weight management.
Clinical studies have shown that people taking Mounjaro® 15mg achieved an average body weight reduction of up to 22.5%, while people taking Wegovy® 7.2mg achieved around 21% average body weight loss when remaining on treatment.
These results were seen in clinical trials where treatment was used alongside lifestyle changes, including a reduced-calorie diet and increased physical activity.
The amount of weight you lose will vary from person to person. Not everyone will reach the highest dose, and your dose should only be increased according to the treatment schedule and the advice of your prescriber.
For the best results, weight management medication should be used alongside sustainable changes to your diet, physical activity and overall lifestyle.